Antibiotic resistance modulation of Clostridium perfringens type D using indigenous plants extracts

Aims@#The study was aimed to explore the antimicrobial potential of ethanolic leaf extracts of Eucalyptus globulus, Moringa oliefera, Syzygium cumini and Citrus limon against antibiotic-resistant Clostridium perfringens type D (n=5).@*Methodology and results@#Antibiotic resistance pattern of C. perfringens type D isolates against tetracycline, gentamicin, ceftriaxone, amoxicillin and streptomycin was evaluated by disc diffusion method. Well diffusion and micro broth dilution methods were used to determine the anti-bacterial activity, sub-inhibitory concentrations and antibiotic resistance modulating effects of the plant extracts. Ethanolic extract of E. globules was selected to evaluate its modulatory impact and subjected to GC-MS analysis to separate and identify the phytochemicals. The results showed that the isolates were resistant to gentamicin (0 ± 0.00 mm), streptomycin (0 ± 0.00 mm), tetracycline (13.2 ± 2.28 mm) and ceftriaxone (0 ± 0.00 mm) while sensitive to amoxicillin (23.8 ± 1.30 mm) and tetracycline (13.2 ± 2.28 mm). Eucalyptus globulus exhibited the maximum anti-bacterial activity with a zone of inhibition (ZOI) of 14.6 ± 0.54 mm and minimum inhibitory concentration (MIC) (1500 ± 947.85 µg/mL). Other plant extracts (M. oliefera, S. cumini and C. limon) also showed anti-bacterial activity but couldn’t modulate the resistance. The activity of ceftriaxone associated with E. globulus extract was improved with 20.2 ± 0.20 mm ZOI at 78.125 µg/mL sub-inhibitory concentration.@*Conclusion, significance and impact of study: @#The study results indicate the possible use of the ethanolic extract of E. globulus alone or in combination with common antibiotics for the treatment of C. perfringens infections in small ruminants.

Caracterização da droga vegetal e solução extrativa obtidos a partir de Syzygium cumini (l. ) skeels para futuro desenvolvimento de formas farmacêuticas / Characterization of the plant drug and extractive solution obtained from Syzygium cumini (l. ) skeels for future development of pharmaceutical forms / Caracterización de la droga vegetal y de la solución extractiva obtenida de Syzygium cumini (l. ) skeels para el futuro desarrollo de formas farmacéuticas

Syzygium cumini (L.) Skeels é uma árvore popularmente conhecida como "jamelão" ou "azeitona-roxa", é um vegetal frutífero de grande porte, pertencente à família Myrtaceae e de origem asiática, teve sua expansão em diversas regiões do mundo, no Brasil é encontrada no Nordeste, Norte e Sudeste. Quando aplicada na medicina tradicional apresenta diversas propriedades farmacológicas contidas em suas folhas, frutos, sementes e caule, com isso torna-se uma espécie bastante promissora para a indústria farmacêutica e alimentícia, pois além de conter características benéficas possui um alto poder econômico. Desta forma, este trabalho visa caracterizar físicoquimicamente a droga vegetal e solução extrativa obtidos a partir das partes aéreas de Syzygium cumini (L.) Skeels para futuro desenvolvimento de forma farmacêutica. O material vegetal de Syzygium cumini (L.) Skeels foi coletado na região de Araçoiaba-PE. Suas partes aéreas foram secas e trituradas. A solução extrativa foi obtida através da maceração da matéria-prima utilizando o etanol como solvente e as caracterizações foram realizadas de acordo com a Farmacopeia Brasileira 6° edição.

Syzygium cumini (L.) Skeels is a tree popularly known as "jamelão" or "olive-purple", is a large fruiting plant, belonging to the Myrtaceae family and of Asian origin, had its expansion in several regions of the world, in Brazil is found in the Nor- theast, North and Southeast. When applied in traditional medicine it presents several phar- macological properties contained in its leaves, fruits, seeds and stem, thus becoming a very promising species for the pharmaceutical and food industry, because besides contai- ning beneficial characteristics it has a high economic power. Thus, this work aims to physicochemically characterize the plant drug and extractive solution obtained from the aerial parts of Syzygium cumini (L.) Skeels for future development of pharmaceutical form. The plant material of Syzygium cumini (L.) Skeels was collected in the region of Araçoiaba-PE. Its aerial parts were dried and triturated. The extractive solution was obtained by maceration of the raw material using ethanol as solvent and the characteriza- tions were performed according to the Brazilian Pharmacopeia 6th edition.

Syzygium cumini (L.) Skeels es un árbol conocido popularmente como "ja- melão" o "oliva-púrpura", es una planta fructífera de gran tamaño, perteneciente a la fa- milia Myrtaceae y de origen asiático, tuvo su expansión en varias regiones del mundo, en Brasil se encuentra en el Nordeste, Norte y Sudeste. Cuando se aplica en la medicina tradicional tiene varias propiedades farmacológicas contenidas en sus hojas, frutos, se- millas y tallo, convirtiéndose así en una especie muy prometedora para la industria far- macéutica y alimentaria, ya que además de contener características beneficiosas tiene un alto poder económico. Así, este trabajo tiene como objetivo caracterizar fisicoquímica- mente la droga vegetal y la solución extractiva obtenida de las partes aéreas de Syzygium cumini (L.) Skeels para el futuro desarrollo de forma farmacéutica. El material vegetal de Syzygium cumini (L.) Skeels fue recolectado en la región de Araçoiaba-PE. Sus partes aéreas fueron secadas y trituradas. La solución extractiva se obtuvo por maceración de la materia prima utilizando etanol como solvente y las caracterizaciones se realizaron de acuerdo con la Farmacopea Brasileña 6ª edición.

Phytochemical composition, antifungal activity, in vitro and in vivo toxicity of Syzygium cumini (L) Skeels leaves extract / Composición fitoquímica, actividad antifúngica, toxicidad in vitro e in vivo del extracto de hojas de Syzygium cumini (L) Skeels

This study determined phytochemical composition, antifungal activity and toxicity in vitro and in vivo of Syzygium cumini leaves extract (Sc). Thus, was characterized by gas chromatography coupled to mass spectrometry and submitted to determination of Minimum Inhibitory (MIC) and Fungicidal concentrations (MFC) on reference and clinical strains of Candida spp. and by growth kinetics assays. Toxicity was verified using in vitro assays of hemolysis, osmotic fragility, oxidant and antioxidant activity in human erythrocytes and by in vivo acute systemic toxicity in Galleria mellonella larvae. Fourteen different compounds were identified in Sc, which showed antifungal activity (MIC between 31.25-125µg/mL) with fungistatic effect on Candida. At antifungal concentrations, it demonstrated low cytotoxicity, antioxidant activity and neglible in vivotoxicity. Thus, Sc demonstrated a promising antifungal potential, with low toxicity, indicating that this extract can be a safe and effective alternative antifungal agent.

Este estudio determinó la composición fitoquímica, la actividad antifúngica y la toxicidad in vitro e in vivo del extracto de hojas de Syzygium cumini (Sc). Así, se caracterizó mediante cromatografía de gases acoplada a espectrometría de masas y se sometió a determinación de Concentraciones Mínimas Inhibitorias (CMI) y Fungicidas (MFC) sobre cepas de referencia y clínicas de Candida spp. y mediante ensayos de cinética de crecimiento. La toxicidad se verificó mediante ensayos in vitro de hemólisis, fragilidad osmótica, actividad oxidante y antioxidante en eritrocitos humanos y por toxicidad sistémica aguda in vivo en larvas de Galleria mellonella. Se identificaron catorce compuestos diferentes en Sc, que mostraron actividad antifúngica (CMI entre 31.25-125 µg/mL) con efecto fungistático sobre Candida. En concentraciones antifúngicas, demostró baja citotoxicidad, actividad antioxidante y toxicidad in vivo insignificante. Por lo tanto, Sc demostró un potencial antifúngico prometedor, con baja toxicidad, lo que indica que este extracto puede ser un agente antifúngico alternativo seguro y eficaz.

Antioxidant activity and hypoglycemic effect assessment of the leaves from Syzygium cumini (L. ) Skeels in Wistar rats

Syzygiumcumini(L.) Skeels wasadaptedto the climatic conditionsandsoil typesin Brazil. Its fruits, leaves andinner barkare usedin folk medicinedue to their highantioxidant, anti-inflammatory, anticarcinogenicandantidiabeticactivities mainlyassociated with the presenceof phenolic compounds. It is estimated thatat least300million peopleworldwide developdiabetesand approximately 11million peopleare carriersof the disease in Brazil.The objectiveof this workwas to evaluate thein vitro antioxidant activity, as well as thehypoglycemic actionofhydroethanolic extract(HEE), the ethyl acetate(EAF) andhydromethanolic(HMF) fractions from leavesofS.cumini(L.) Skeels in rats. All assays werecarried out in three replications. Data wereexpressed as meanSDand significance was evaluated by ANOVAand Bonferronitest (p < 0.05). The results indicatea significant(p < 0.05) total phenolcontent (207 ± 2.3GAE mg g-1) andantioxidant activity(EC50=9.05±0.170 µg mL-1) for EAF. HEE and its fractions showed no significant (p > 0.05) actionto modulateglucosebytheOGTT assayinnondiabetic micecompared to control. Thus the use of the plant against diabetes in individuals is not proven.

WHO prescribed shelf life assessment of Syzygium cumini extract through chromatographic and biological activity analyses

Background: Regulatory guidelines recommend shelf life of herbal products to be established throughsystematic stability studies.Objective: The study was designed to establish shelf life of Syzygium cumini extract through acceleratedand long-term stability testing as per WHO guidelines.Material and methods: The extract was stored under accelerated (40_x005F_x005F_x0001_C/75 %RH) and long-term (25_x005F_x005F_x0001_C/60%RH) stability conditions for 6 and 30 months, respectively. Samples were withdrawn at periodic intervals and analysed through two validated HPLC-UV methods (I and II) for fingerprint and quantitativeanalysis of markers. Antidiabetic activity of control and stability samples was evaluated by a-glucosidaseinhibitory model.Results: Method I generated a well resolved fingerprint of the control sample that was found to containgallic acid (GA, 1.45 % w/w) and ellagic acid (EA, 3.97 % w/w). The content of GA did not change underboth the stability conditions, but that of EA varied insignificantly (3.97e4.77 % w/w) under long-termconditions up to 24 months and subsequently decrease to 3.15 % w/w after 30 months. There was novisible change in LC-UV fingerprint of any stability sample with respect to control. a-Glucosidaseinhibitory activity of all stability samples also remained unaltered as compared to control sample (IC501.48 mg/mL). GA and EA did not elicit any activity at the concentrations present in the extract.Conclusion: Phytochemical composition and antidiabetic efficacy of S. cumini extract remain unchangedduring its storage under both accelerated and long-term stability conditions, which suggest its shelf lifeto be 30 months. Also, GA and EA are not appropriate anti-diabetic markers

Syzygium cumini (jamun) therapeutic potential: a comprehensive review on phytochemical constituents and emphasis on its pharmacological actions related to diabetic intervention

Syzygium cumini or Eugenia Jambolana Lam is a traditional medicinal plant very native to the Indian and Asian sub-continent. It is commonly known as black plum or jamun. Various plants parts of the tree are known for ethno-medicinal uses, and in particular, the fruits of Jamun tree are well known for medicinal uses and preparation of health drinks. Studies have shown that the berries contain carbohydrates, minerals and the pharmacologically active phytochemicals. The active phytochemical includes flavonoids, terpenes, and anthocyanins. Ayurvedic and Indian Folk Medicine have already mentioned the use of jamun for diabetic treatment even before the advent of insulin. The bark, fruit pulp, seeds and the leaves are evaluated in the crude form as well as extracts in various diabetic models. Further, bioactive phytochemicals are extracted using in vitro assays, some of them such as vitalboside-A, mycominose are also characterized with spectroscopic analysis. This review article is intended to compile Syzygium cumini’s therapeutic potential with special emphasis on the phytochemical constituents and its pharmacological activities related to diabetic intervention through recent studies conducted in last one decade. It also addresses the clinical and toxicological studies.

Desenvolvimento de filmes biodegradaveis antimicrobianos a partir da incorporação de extrato de jamelão / Development of antimicrobial biodegradable films from the incorporation of jamelão extract

O objetivo do presente trabalho foi desenvolver filmes biodegradáveis antimicrobianos a partir da incorporação do extrato bioativo proveniente da casca do fruto Jamelão. Para tal, foi obtido inicialmente o extrato das cascas em pó e depois foram elaborados filmes biodegradáveis utilizando acetato de celulose e amido+quitosana. Os filmes foram incorporados do extrato em diferentes concentrações para então serem avaliados quanto as suas propriedades antimicrobiana frente às cepas de Staphylococcus aureus e Listeria monocytogenes. Os resultados mostraram que nos filmes de acetato, não houve formação de halo de inibição frente a nenhuma das bactérias testadas, independentemente da concentração de extrato aplicado. Por outro lado, para os filmes de amido com quitosana, foi constatada atividade para as duas bactérias testadas e que à medida que se aumentava a concentração do extrato, aumentavam-se também os tamanhos dos halos de inibição. Logo estes podem ser aplicados em alimentos.

Protective role of Syzygium cumini leaf extracts against paraquat-induced oxidative stress in superoxide-dismutase-deficient Saccharomyces cerevisiae strains

The aim of this study was to evaluate the protective effect of three different extracts prepared from Syzygium cumini leaves against paraquat-induced toxicity in Saccharomyces cerevisiaestrains deficient in superoxide dismutase (SOD). Additionally, the extracts phenolic and flavonoid contents, in vitro antioxidant activity, and phytochemical composition (using high-pressure liquid chromatography) were determined. Bioactive compounds from S. cumini leaves were extracted with infusion (traditional method) or ultrasound (aqueous or hydroalcoholic). Compared to the infusion extract, the ultrasound extracts exhibited a greater protective capacity against paraquat toxicity in the yeast cells as well as higher antioxidant activity. These results may be directly related to the higher phenolic and flavonoid contents in these extracts, since they are recognized as having high antioxidant actions.

Cardio-and hepato-protective potential of methanolic extract of Syzygium cumini (L.) Skeels seeds:A diabetic rat model study

Objective: To evaluate the effect of methanolic extract of Syzygium cumini (L.) Skeels (S. cumini) seeds on the major organs in an animal model of diabetes through biochemical and histopathological studies. Methods: The methanolic extracts of S. cumini seeds (100 and 200 mg/kg body weight) were administered to alloxan-induced diabetic rats daily, with fasting blood glucose levels being measured by glucometry at one-day interval for a duration of two weeks. Biochemical assays to evaluate changes in the functions of the heart, liver, pancreas and kidney were carried out. Histopathological changes in the diabetic rat organs (pancreas, liver, heart, kidney and spleen) were also observed after the 14 days of treatment with the extracts. Results: Oral administration of methanolic extracts of S. cumini seeds (100 and 200 mg/kg body weight), with gliclazide as a positive control (25 mg/kg), showed beneficial effects including lowering blood glucose levels (P < 0.001), improved heart and liver functions, and hyperlipidemia due to diabetes. At 200 mg/kg, the extracts reversed car-diac and liver damage caused by alloxan. Conclusions: In addition to the anti-hyperglycemic activity of methanolic extracts of S. cumini seeds, the extracts demonstrates potential to minimize cardiac and hepatic complications.

Cardio- and hepato-protective potential of methanolic extract of Syzygium cumini (L.) Skeels seeds: A diabetic rat model study

Objective To evaluate the effect of methanolic extract of Syzygium cumini (L.) Skeels (S. cumini) seeds on the major organs in an animal model of diabetes through biochemical and histopathological studies. Methods The methanolic extracts of S. cumini seeds (100 and 200 mg/kg body weight) were administered to alloxan-induced diabetic rats daily, with fasting blood glucose levels being measured by glucometry at one-day interval for a duration of two weeks. Biochemical assays to evaluate changes in the functions of the heart, liver, pancreas and kidney were carried out. Histopathological changes in the diabetic rat organs (pancreas, liver, heart, kidney and spleen) were also observed after the 14 days of treatment with the extracts. Results Oral administration of methanolic extracts of S. cumini seeds (100 and 200 mg/kg body weight), with gliclazide as a positive control (25 mg/kg), showed beneficial effects including lowering blood glucose levels (P < 0.001), improved heart and liver functions, and hyperlipidemia due to diabetes. At 200 mg/kg, the extracts reversed cardiac and liver damage caused by alloxan. Conclusions In addition to the anti-hyperglycemic activity of methanolic extracts of S. cumini seeds, the extracts demonstrates potential to minimize cardiac and hepatic complications.